Cerus (CERS) Q3 2026 Earnings Call Transcript
REDeS trial met efficacy endpoints; ISC revenue surged 44% year over year.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.